Headlands Technologies LLC Acquires Shares of 162 Teleflex Incorporated (NYSE:TFX)

Headlands Technologies LLC bought a new stake in shares of Teleflex Incorporated (NYSE:TFX) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 162 shares of the medical technology company’s stock, valued at approximately $29,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of TFX. HighTower Advisors LLC boosted its stake in shares of Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after purchasing an additional 66 shares during the period. Hengehold Capital Management LLC grew its stake in Teleflex by 7.3% in the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock worth $229,000 after purchasing an additional 88 shares in the last quarter. Exchange Traded Concepts LLC raised its position in Teleflex by 38.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after purchasing an additional 94 shares in the last quarter. Isthmus Partners LLC lifted its holdings in shares of Teleflex by 7.3% in the 4th quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock worth $273,000 after buying an additional 105 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its position in shares of Teleflex by 2.4% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company’s stock worth $888,000 after buying an additional 118 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Down 2.6 %

NYSE:TFX opened at $127.35 on Wednesday. The company’s 50 day moving average is $151.67 and its two-hundred day moving average is $184.24. The company has a market cap of $5.90 billion, a PE ratio of 25.32, a P/E/G ratio of 1.73 and a beta of 1.19. Teleflex Incorporated has a twelve month low of $125.92 and a twelve month high of $249.91. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.07%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s payout ratio is 95.77%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on TFX. Raymond James cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Truist Financial dropped their target price on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research report on Monday, March 3rd. Citizens Jmp cut Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. Finally, Morgan Stanley reduced their target price on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a report on Wednesday, March 5th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.